L3Harris Technologies Pushes Missile IPO to Mid-2027, Unveils $12 Billion THAAD-PAC-3 Framework as Aerojet Turnaround Validates
Q2 2026 earnings call, July 29, 2026
L3Harris Technologies used its second-quarter call to deliver one of the more consequential updates in its multiyear Trusted Disruptor strategy, disclosing a delay to its long-anticipated missile business IPO alongside a newly signed $12 billion, seven-year production framework with Lockheed Martin for THAAD and PAC-3 interceptor components. The combination of a pushed-out spinoff timeline and a massive new contract vehicle reframes how investors should think about the pace and shape of value creation in the company's Missile Solutions segment, formerly built around the Aerojet Rocketdyne acquisition.
IPO Timeline Slips to Mid-2027
The headline surprise was CEO Chris Kubasik's confirmation that the company is pushing its planned missile business IPO to mid-2027, later than the market had been positioned for. Kubasik was direct about the rationale, telling analysts that "the market conditions do not reflect the value we're building" and pointing to a broader repricing of recent defense-adjacent IPOs as the source of the mismatch. "I think, unfortunately, a lot of the recent IPOs are obviously missing some or all of those key elements to a business and the market is adjusting to valuation. I think we're kind of caught in that process a little bit," he said.
Kubasik added that the bulk of the capital the business will need doesn't arrive until "late '27, '28 and '29," making an earlier listing less urgent than previously implied, and said the decision was unanimous within the leadership team. CFO Ken Sharp reinforced that the delay does not reflect a slowdown in fundamentals, guiding to high-teens revenue growth for the missile business "for the foreseeable future" as roughly 60 new manufacturing facilities come online through 2029. Retention agreements for senior missile leadership were extended alongside the announcement, addressing a question from Wolfe Research's Myles Walton about execution continuity through the delay.
$12 Billion THAAD-PAC-3 Framework Signals Durable Demand
Shortly after quarter-end, L3Harris signed a seven-year framework agreement with Lockheed Martin covering THAAD and PAC-3 interceptor production, representing approximately $12 billion of future revenue and $2 billion of future profit. The company is working to quadruple THAAD production, supplying all solid rocket motors and Divert and Attitude Control Systems, while nearly tripling PAC-3 output across solid rocket motors, Attitude Control Motors and Lethality Enhancers. As the sole producer of PAC-3 solid rocket motors at scale, and with sole-source positions on the associated control motors and lethality enhancers, Kubasik said the company sees room to deliver volumes "above the 80% framework agreement" to backstop competitor shortfalls and address international demand sooner.
On the margin math, Vertical Research's Robert Stallard calculated a roughly 17% implied margin on the framework. Kubasik didn't dispute the estimate, guiding toward "something in the 15%, 17%, 18% range... especially as we ramp up with volume and get the supply chain lined up." A new, highly automated PAC-3 facility is expected online in late 2027, which management frames as the capacity backstop that "no one else" in the industry can match.
Aerojet Turnaround Metrics Come Into Focus
Kubasik used the call to lay out, in unusually granular terms, how the Aerojet Rocketdyne acquisition has been transformed since its full-price purchase three years ago — a deal he acknowledged was unpopular at the time given questions over multiple, integration risk and execution capability. Deliveries are up more than 60%, delinquent deliveries have been "substantially" eliminated, and manufacturing efficiency has improved 22%. R&D and capex investment into the missile business has increased by a factor of ten since the deal closed.
The Department of War's $1 billion preferred equity investment into the business was framed not just as a validation signal but as a catalyst that pulled forward the capacity build by 12 to 18 months. The new GMLRS facility — dubbed the "Arsenal of Freedom" building — opens next month, featuring automated motor handling, mixing, casting, curing and AI-overlaid X-ray inspection, and is expected to more than double GMLRS capacity while cutting manufacturing time in half. "The conversations we're having with the Pentagon are no longer about whether we can deliver, but how many can we produce and how fast we can go," Kubasik said, calling it "a complete turnaround from a year ago."
Management also disclosed it is negotiating more than $20 billion in additional contracts that could triple the segment's current backlog, and committed $2 billion toward missile capacity, facilities, equipment and supply chain — of which $136 million in capacity investment, including finance leases, landed in the quarter alone.
Guidance Raised Despite Divestiture Headwind
L3Harris raised full-year 2026 revenue guidance to $23.2 billion-$23.7 billion, implying organic growth of 8% to 10%, and lifted EPS guidance by $0.40 to $11.80-$12.00 — even after absorbing an approximate $0.20 per share headwind from the pending sale of a majority interest in its commercial space propulsion business, expected to close in August. That divested unit generated $571 million of revenue and $82 million of segment profit in 2025. Segment operating margin guidance held at low-16%, and free cash flow guidance was reaffirmed at $3 billion. Second-quarter results showed revenue up 8% year-over-year to $5.9 billion, GAAP EPS of $3.13 (up 28%), and free cash flow of $771 million, up 37%. Book-to-bill came in at 1.2x for the quarter and 1.3x on a trailing-twelve-month basis, with backlog rising past $1 billion to $42 billion.
International sales rose more than 20% and now represent 23% of total revenue, up roughly 250 basis points over the past year — a trend management linked to $3 billion in airborne early warning and control awards since the fourth quarter and a stated $10 billion pipeline across the Middle East, Asia Pacific and Europe.
Shield Capital Venture Stakes Disclosed for the First Time
In response to a question from Morgan Stanley's Kristine Liwag, Kubasik disclosed financial details of the company's four-year-old venture partnership with Shield Capital that hadn't previously been made public: L3Harris has committed roughly $50 million each to two Shield Capital funds, with Fund I about 70-80% drawn and Fund II 10-20% drawn. Sharp confirmed the relationship is now generating investment gains that flow through below operating income, contributing to the EPS beat this quarter. Kubasik described the strategic logic as threefold — pulling dual-use technology into L3Harris products, accelerating R&D without the multi-year internal build cycle, and generating direct investment returns as portfolio companies appreciate — and said the firm is looking forward to Shield's Fund III.
Capital Allocation Priorities With $4 Billion of Cash
With divestiture proceeds and free cash flow, L3Harris expects to hold approximately $4 billion in cash by year-end before any debt paydown or buybacks. Sharp laid out a hierarchy: business investment first, followed by debt reduction — leverage has already come down to 2.3 turns — and then share repurchases, with the company keeping an eye on preserving its 24-year dividend growth streak toward Dividend Aristocrat status. Sharp noted the firm isn't actively pursuing bolt-on M&A at current valuations, calling it a matter of "the valuations have to be right." Kubasik added that capex will increasingly shift toward digitization and AI-embedded infrastructure alongside the roughly 60 new missile-related buildings under construction.